A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer.
Yuji HakozakiHisashi MatsushimaJimpei KumagaiTaro MurataTomoko MasudaYoko HiraiMai OdaNobuo KawauchiMunehiro YokoyamaYukio HommaPublished in: BMC urology (2017)
This study was retrospectively registered at the University Hospital Medical Information Network ( UMINID000025911 ) in Jan 30, 2017.